Snapshot from Aug 25, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / Bronstein, Gewirtz & Grossman, LLC / Aldeyra Therapeutics

Bronstein, Gewirtz & Grossman, LLC & Aldeyra Therapeutics

2 shared events · Importance 3 · Last updated May 07, 2026

Importance
3
Shared Events
2
Actions
0
Sentiment
0
Live sentiment trends, interaction importance charts, and action volume tracking available on the Ergen Dashboard
Shared Events (2)
92
Business
Aldeyra Therapeutics Faces Class Actions
Bronstein, Gewirtz & Grossman, LLC: Bronstein, Gewirtz & Grossman, LLC is an investor-rights law firm that has filed a class action lawsuit against Aldeyra Therapeutics, seeking to recover damages for investors.
Aldeyra Therapeutics: Aldeyra Therapeutics is the primary defendant in multiple class action lawsuits filed by various law firms, alleging that the company made false and misleading statements regarding the clinical trials of its drug candidate, reproxalap. The company's stock price fell significantly after the United States — Food and Drug Administration issued a Complete Response Letter for reproxalap.
Apr 24, 2026 · 80 articles
0
Business
Aldeyra Therapeutics Faces Class Action Lawsuits
Apr 01, 2026 · 74 articles
ERGEN INTELLIGENCE
Explore this relationship live

Track how Bronstein, Gewirtz & Grossman, LLC and Aldeyra Therapeutics interact across events, view sentiment trends, and discover connected entities.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.